Allecra Therapeutics receives FDA approval for treatment targeting severe UTIs
Allecra Therapeutics, a biopharma company developing novel therapies to combat antibiotic resistance, has received FDA approval for its treatment tackling ‘complicated’ urinary tract infections (UTIs).
Patrick Velicitat Omar Lahlou Iain Buchanan Committee For Medicinal Products Human European Medicines Agency Us Congress
Source: biopharma-reporter.com